Literature DB >> 1374227

Localisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis.

D A Walsh1, P I Mapp, J Wharton, R A Rutherford, B L Kidd, P A Revell, D R Blake, J M Polak.   

Abstract

The neuropeptide substance P is found in perivascular and free unmyelinated nerve fibres in human synovial tissue. Quantitative receptor autoradiography was used to show specific, high affinity (Kd = 0.75 (0.21), nmol/l (mean (standard error of the mean)), low capacity (Bmax = 27.8 (7.9) amol/mm2) binding sites for substance P Bolton Hunter-labelled with iodine-125 localised to vascular endothelial cells in human synovial tissue. The binding could be saturated, was reversible, and was dependent on the magnesium concentration. Unlabelled substance P and neurokinin A competitively inhibited specific binding with 50% inhibition at concentrations of 1.25 (0.21) and 175 (29) nmol/l respectively. Neurokinin B (mumol/l) and calcitonin gene related peptide (1 mumol/l) did not inhibit binding. These binding sites show characteristics of the neurokinin 1 tachykinin receptor subtype. This provides further evidence that substance P may play a part in the vascular control of human synovium and may influence inflammatory processes in joints.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374227      PMCID: PMC1004650          DOI: 10.1136/ard.51.3.313

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  25 in total

1.  Unilateral rheumatoid arthritis following hemiplegia.

Authors:  M THOMPSON; E G BYWATERS
Journal:  Ann Rheum Dis       Date:  1962-12       Impact factor: 19.103

Review 2.  Neuropeptides and immunity.

Authors:  A Stanisz; R Scicchitano; R Stead; H Matsuda; M Tomioka; J Denburg; J Bienenstock
Journal:  Am Rev Respir Dis       Date:  1987-12

3.  Substance P release from knee joint afferent terminals: modulation by opioids.

Authors:  T L Yaksh
Journal:  Brain Res       Date:  1988-08-23       Impact factor: 3.252

4.  Substance P and arthritis: analysis of plasma and synovial fluid levels.

Authors:  K W Marshall; B Chiu; R D Inman
Journal:  Arthritis Rheum       Date:  1990-01

5.  Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis.

Authors:  P I Mapp; B L Kidd; S J Gibson; J M Terry; P A Revell; N B Ibrahim; D R Blake; J M Polak
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

Review 6.  Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis.

Authors:  J D Levine; D H Collier; A I Basbaum; M A Moskowitz; C A Helms
Journal:  J Rheumatol       Date:  1985-06       Impact factor: 4.666

7.  Extravasation in the knee induced by antidromic stimulation of articular C fibre afferents of the anaesthetized cat.

Authors:  W R Ferrell; N J Russell
Journal:  J Physiol       Date:  1986-10       Impact factor: 5.182

8.  Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis.

Authors:  M Lotz; D A Carson; J H Vaughan
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

9.  Multiple tachykinin binding sites in peripheral tissues and in brain.

Authors:  C M Lee; N J Campbell; B J Williams; L L Iversen
Journal:  Eur J Pharmacol       Date:  1986-11-04       Impact factor: 4.432

10.  Rapidly progressive Charcot arthropathy following minor joint trauma in patients with diabetic neuropathy.

Authors:  S D Slowman-Kovacs; E M Braunstein; K D Brandt
Journal:  Arthritis Rheum       Date:  1990-03
View more
  14 in total

Review 1.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  NK1 receptors mediate tachykinin-induced plasma extravasation in the rat knee joint.

Authors:  Y Hirayama; R Yasumitsu; A Kawamura; T Fujii
Journal:  Agents Actions       Date:  1993-11

Review 3.  Innervation of the synovium.

Authors:  P I Mapp
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

4.  Soluble recombinant neutral endopeptidase (CD10) as a potential antiinflammatory agent.

Authors:  N J Solan; P E Ward; S P Sanders; M C Towns; J M Bathon
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

5.  The effects of substance p on tendinopathy are dose-dependent: an in vitro and in vivo model study.

Authors:  Y Zhou; B Zhou; K Tang
Journal:  J Nutr Health Aging       Date:  2015-05       Impact factor: 4.075

6.  A role for the sensory neuropeptide calcitonin gene-related peptide in endothelial cell proliferation in vivo.

Authors:  Paul I Mapp; Daniel F McWilliams; Matthew J Turley; Edward Hargin; David A Walsh
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

7.  Visualization of the thymus by substance P receptor scintigraphy in man.

Authors:  P M van Hagen; W A Breeman; J C Reubi; P T Postema; P J van den Anker-Lugtenburg; D J Kwekkeboom; J Laissue; B Waser; S W Lamberts; T J Visser; E P Krenning
Journal:  Eur J Nucl Med       Date:  1996-11

8.  Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists.

Authors:  T P Fan; D E Hu; S Guard; G A Gresham; K J Watling
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

9.  Neuropeptide degrading enzymes in normal and inflamed human synovium.

Authors:  D A Walsh; P I Mapp; J Wharton; J M Polak; D R Blake
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Relevance of Somatostatin Receptors and Other Peptide Receptors in Pathology.

Authors:  Jean Claude Reubi
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.